Immunogen reported $5.5M in Stock for its fiscal quarter ending in September of 2023.



Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Agios Pharmaceuticals USD 35.09M 2.17M Mar/2026
Amgen USD 6.19B 39M Mar/2026
Astellas Pharma JPY 297.26B 9.92B Mar/2025
AstraZeneca USD 6.57B 13M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Exelixis USD 26.6M 4.92M Mar/2026
Halozyme Therapeutics USD 155.47M 21.01M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 9.5M 1.59M Mar/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 10.67B 13M Mar/2026
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025
Sanofi EUR 22.69B 1.81B Dec/2025